CVS Health Corporation (NYSE:CVS) declared a quarterly dividend on Thursday, September 22nd. Shareholders of record on Monday, October 24th will be given a dividend of 0.425 per share by the pharmacy operator on Thursday, November 3rd. This represents a $1.70 dividend on an annualized basis and a yield of 1.88%.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Pinkerton Retirement Specialists LLC increased its position in CVS Health Corporation by 3,475.0% in the second quarter. Pinkerton Retirement Specialists LLC now owns 1,144 shares of the pharmacy operator’s stock valued at $110,000 after buying an additional 1,112 shares during the last quarter. Cantab Capital Partners LLP increased its position in CVS Health Corporation by 355.4% in the second quarter. Cantab Capital Partners LLP now owns 1,184 shares of the pharmacy operator’s stock valued at $113,000 after buying an additional 924 shares during the last quarter. MCF Advisors LLC increased its position in CVS Health Corporation by 20.0% in the second quarter. MCF Advisors LLC now owns 1,212 shares of the pharmacy operator’s stock valued at $116,000 after buying an additional 202 shares during the last quarter. Valley National Advisers Inc. increased its position in CVS Health Corporation by 0.5% in the second quarter. Valley National Advisers Inc. now owns 1,790 shares of the pharmacy operator’s stock valued at $171,000 after buying an additional 9 shares during the last quarter. Finally, FCG Advisors LLC acquired a new position in CVS Health Corporation during the second quarter valued at $200,000. Institutional investors and hedge funds own 80.96% of the company’s stock.

Shares of CVS Health Corporation (NYSE:CVS) traded up 0.13% on Thursday, reaching $90.38. 5,068,591 shares of the company traded hands. The firm has a market capitalization of $96.36 billion, a P/E ratio of 20.79 and a beta of 0.84. CVS Health Corporation has a 1-year low of $86.50 and a 1-year high of $106.67. The stock has a 50-day moving average price of $94.41 and a 200 day moving average price of $97.92.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/22/cvs-health-corporation-cvs-announces-0-43-quarterly-dividend.html

CVS Health Corporation (NYSE:CVS) last issued its earnings results on Tuesday, August 2nd. The pharmacy operator reported $1.32 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.30 by $0.02. CVS Health Corporation had a net margin of 2.88% and a return on equity of 15.86%. The company had revenue of $43.70 billion for the quarter, compared to analysts’ expectations of $44.28 billion. During the same quarter last year, the company posted $1.19 earnings per share. The firm’s quarterly revenue was up 17.6% on a year-over-year basis. Analysts anticipate that CVS Health Corporation will post $5.86 EPS for the current fiscal year.

A number of research firms have issued reports on CVS. Deutsche Bank AG lifted their price target on CVS Health Corporation from $99.00 to $105.00 and gave the company a “hold” rating in a research note on Wednesday, June 22nd. Argus reissued a “buy” rating and set a $120.00 target price on shares of CVS Health Corporation in a research report on Thursday, August 4th. Leerink Swann reissued a “buy” rating on shares of CVS Health Corporation in a research report on Wednesday, August 3rd. Zacks Investment Research raised shares of CVS Health Corporation from a “sell” rating to a “hold” rating in a research report on Wednesday, August 3rd. Finally, Mizuho lifted their target price on shares of CVS Health Corporation from $108.00 to $111.00 and gave the stock a “buy” rating in a research report on Thursday, August 4th. Six investment analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has given a strong buy rating to the company. CVS Health Corporation currently has a consensus rating of “Buy” and an average target price of $113.02.

CVS Health Corporation Company Profile

CVS Health Corporation, together with its subsidiaries, is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail Pharmacy and Corporate. The Pharmacy Services segment provides a range of pharmacy benefit management (PBM) services and operates under the CVS/caremark Pharmacy Services, Novologix and Navarro Health Services names.

5 Day Chart for NYSE:CVS

Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.